Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cnbx Pharmaceuticals Inc (CNBX)

Cnbx Pharmaceuticals Inc (CNBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
Trade CNBX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0100 +24.00%
on 04/17/24
0.0175 -29.14%
on 03/25/24
-0.0013 (-9.49%)
since 03/21/24
3-Month
0.0085 +45.88%
on 01/31/24
0.0180 -31.11%
on 02/15/24
-0.0026 (-17.33%)
since 01/23/24
52-Week
0.0085 +45.88%
on 01/31/24
0.0487 -74.54%
on 09/13/23
-0.0106 (-46.09%)
since 04/21/23

Most Recent Stories

More News
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0124 (+3.33%)
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

/PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0124 (+3.33%)
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the...

CNBX : 0.0124 (+3.33%)
CNBX Pharmaceuticals Announces New Patent Granted in Australia

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0124 (+3.33%)
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0124 (+3.33%)
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0124 (+3.33%)
CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0124 (+3.33%)
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0124 (+3.33%)
Seedo Corp. Appoints New Board of Directors

Yoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC: SEDO) (“Seedo”) announced its shareholders have elected a new Board of Directors. The new Board brings decades of executive corporate,...

SEDO : 0.1310 (-12.90%)
BGEO.LN : 5,160.000 (+5.41%)
CNBX : 0.0124 (+3.33%)
XAIR : 1.2100 (unch)
APOP : 13.17 (+0.38%)
XTLB : 2.59 (-2.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

American Mining Corp was incorporated on September 15, 2004. The Company is an exploration stage company. The Company acquires mineral exploration rights throughout North America, exploring for commercially producible quantities of minerals, and exploiting any mineral deposits which demonstrate economic...

See More

Key Turning Points

3rd Resistance Point 0.0134
2nd Resistance Point 0.0131
1st Resistance Point 0.0127
Last Price 0.0124
1st Support Level 0.0120
2nd Support Level 0.0117
3rd Support Level 0.0113

See More

52-Week High 0.0487
Fibonacci 61.8% 0.0333
Fibonacci 50% 0.0286
Fibonacci 38.2% 0.0239
Last Price 0.0124
52-Week Low 0.0085

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar